Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · IEX Real-Time Price · USD
3.240
+0.020 (0.62%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $429.53 million as of July 26, 2024. Its market cap has decreased by -10.83% in one year.
Market Cap
429.53M
Enterprise Value
456.41M
1-Year Change
-10.83%
Ranking
Category
Stock Price
$3.24
Market Cap Chart
Since January 5, 2017, Organogenesis Holdings's market cap has increased from $376.60M to $429.53M, an increase of 14.06%. That is a compound annual growth rate of 1.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 429.50M | -20.46% |
| Dec 29, 2023 | 540.00M | 53.32% |
| Dec 30, 2022 | 352.20M | -70.37% |
| Dec 31, 2021 | 1.19B | 46.45% |
| Dec 31, 2020 | 811.60M | 78.10% |
| Dec 31, 2019 | 455.70M | 30.13% |
| Dec 31, 2018 | 350.20M | -8.90% |
| Dec 29, 2017 | 384.40M | 2.07% |
| Jan 5, 2017 | 376.60M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C4 Therapeutics | 445.86M |
| Cerus | 441.89M |
| Korro Bio | 439.17M |
| Ocugen | 437.50M |
| Lyell Immunopharma | 430.85M |
| Precigen | 416.49M |
| Anika Therapeutics | 416.45M |
| AxoGen | 413.01M |